Financials
- Market Capitalization 19.46 M
- Employee 14
- Founded 2008
- CEO Steven C. Quay
- Website www.atossatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002NCD8C8
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 4597 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.63 USD | 0.00% | -2.59% | +11.91% | -16.24% | 21.02 M USD | ||
| 4612 | JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.72 USD | +18.03% | +50.00% | +53.19% | -78.57% | 20.16 M USD | ||
| 4625 | LGVN Longeveron Inc. - Class A Common stock | 0.62 USD | -1.59% | -3.13% | -21.52% | +8.52% | 19.31 M USD | ||
| 4626 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.57 USD | +2.29% | -0.83% | -16.59% | -52.90% | 19.29 M USD |